US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,302.78

+0.39700.03%

Number of Gainers:5

Number of Losers:2

Number of Flat:- -

PE:- -

High:1,317.57

Open:1,302.35

Low:1,301.26

Close:1,302.41

Volume:68.41M

Turnover:4.57B

Market Cap:1.38T

Float Cap:1.30T

Loading ...

Martin Capital Dumps $3.0 Million Worth of LyondellBasell Industries Stock

Amgen Shares Down 1.5% After Co to Sell Cholesterol Drug at 60% Discount to Cash-Paying US Patients

THOMSON REUTERS

BUZZ-Amgen stock falls as Repatha gets direct sales price cut

BUZZ-COVID vaccine makers fall after US CDC pulls support for the shot

Martin Capital Liquidates its Diageo Position: What That Means for the Alcoholic Beverages Titan

Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years. -- Barrons.com

Eli Lilly Announces $1 Billion Investment in India to Expand Manufacturing Operations

GoodRx Expands Affordable Access to Cholesterol Drug Repatha

MT Newswires Live

Amgen Introduces Direct-to-Patient Access for Repatha in US

MT Newswires Live

BRIEF-Amgen Makes Repatha® Available Through Amgennow, A Direct-To-Patient Program In The U.S.

Amgen Makes Repatha® Available Through Amgennow, a Direct-to-Patient Program in the U.S.

THOMSON REUTERS

Amgen: Program Open to All Patients, Including Those Who Are Uninsured or in High-Deductible Health Plans or Prefer to Pay With Cash or Out of Pocket

THOMSON REUTERS

Amgen: Repatha to Be Available Through Amgennow at a Monthly Price of $239, Nearly 60% Lower Than Current U.S. List Price

THOMSON REUTERS

Amgen to sell cholesterol drug at 60% discount direct to US consumers

Amgen: Plans to Make Amgennow Accessible via the Trumprx Website

THOMSON REUTERS

Press Release: Phathom Pharmaceuticals Appoints Sanjeev Narula as Chief Financial and Business Officer

Eli Lilly Plans to Invest Over $1 Billion in India to Boost Production Capacity for Weight Loss Drugs and Other Key Medications

3 Reasons to Buy Pfizer Stock Now

Eli Lilly to Invest Over $1 Bln in India to Collaborate With Contract Drugmakers

THOMSON REUTERS

2 Beaten-Down Stocks Primed for a Comeback

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4599/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1302.8049,"timestamp":1759778783797,"preClose":1302.408,"halted":0,"volume":68407828,"delay":0,"changeRate":0.000305,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":0.396973,"latestTime":"10-06 15:26:24 EDT","open":1302.3533,"high":1317.5665,"low":1301.2638,"amount":4573091401.727128,"amplitude":0.012517,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1759780800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.257822,"peRate":27.400454,"turnoverRate":0.006465,"increases":5,"decrements":2,"flats":0,"marketCap":1381511540512,"floatMarketCap":1304393737600},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1317.5665,"amplitude":0.012517,"preClose":1302.408,"low":1301.2638,"pbRate":"9.257822","latestPrice":1302.7773,"volume":68411495,"delay":0,"open":1302.3533,"prevYearClose":1305.0607,"prevWeekClose":1302.408,"prevMonthClose":1197.2607,"prevQuarterClose":1197.2607,"fiveDayClose":1150.1018,"twentyDayClose":1163.9327,"sixtyDayClose":1274.6445,"secType":"PLATE","market":"US","turnoverRate":0.006465,"peRate":27.400454,"marketCap":1381511540512,"floatMarketCap":1304393737600,"timestamp":1759778785294,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2573602108","title":"Martin Capital Dumps $3.0 Million Worth of LyondellBasell Industries Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2573602108","media":"Motley Fool","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573602108?lang=en_us&edition=fundamental","pubTime":"2025-10-07 02:03","pubTimestamp":1759773780,"startTime":"0","endTime":"0","summary":"Exited 51,431 shares in LyondellBasell Industries; estimated trade value of approximately $3.0 million, based on the average share price during Q3 2025. Previously, the position accounted for 1.17% of fund AUM as of Q3 2025","market":"fut","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F2aaa0626f8846fe4dc9ac3102ff548ca70099aff-1536x1024.png&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F2aaa0626f8846fe4dc9ac3102ff548ca70099aff-1536x1024.png&op=resize&w=165&h=104"],"rights":{"source":"fool_stock","url":"https://www.fool.com/coverage/filings/2025/10/06/martin-capital-dumps-usd3-0-million-worth-of-lyondellbasell-industries-n-v-stock/","rn_cache_url":null,"customStyle":"","selectors":".main-contain, #article-page","filters":"#sticky-wrapper, .navigation, .article-page-end, .foot, .author-tagline, .author-inline, .footer, .soc-share, .wysiwyg, .related-content","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/coverage/filings/2025/10/06/martin-capital-dumps-usd3-0-million-worth-of-lyondellbasell-industries-n-v-stock/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1057294990.SGD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0058720904.USD","BK4588","BK4566","LU2242646821.SGD","BK4533","BK4139","IE00B2B36J28.USD","LU0320765992.SGD","BK4099","IE00B4R5TH58.HKD","LU2242652126.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1023059063.AUD","LU0868494617.USD","BK4599","LU1061106388.HKD","LU1571399168.USD","LU0289739699.SGD","LU2468319806.SGD","BK4581","BK4523","SG9999001440.SGD","LU2089984988.USD","TTM","LU0122379950.USD","AMGN","LU2112291526.USD","LU1983299246.USD","IE0009355771.USD","BK4534","BK4585"],"gpt_icon":0},{"id":"2573602369","title":"Amgen Shares Down 1.5% After Co to Sell Cholesterol Drug at 60% Discount to Cash-Paying US Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2573602369","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573602369?lang=en_us&edition=fundamental","pubTime":"2025-10-07 01:45","pubTimestamp":1759772717,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nL3N3VN105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2242652126.USD","LU1057294990.SGD","LU2242646821.SGD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE0009355771.USD","LU2468319806.SGD","BK4139","LU1571399168.USD","LU2112291526.USD","LU0122379950.USD","LU0889565916.HKD","LU1061106388.HKD","IE0002141913.USD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4581","LU0058720904.USD","LU1983299246.USD","BK4534","LU0868494617.USD","AMGN","BK4599","LU2089984988.USD","IE00BJT1NW94.SGD","BK4585","BK4588","BK4533","IE00BJJMRZ35.SGD","BK4566","LU0289739699.SGD","SG9999001440.SGD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2573040616","title":"BUZZ-Amgen stock falls as Repatha gets direct sales price cut","url":"https://stock-news.laohu8.com/highlight/detail?id=2573040616","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573040616?lang=en_us&edition=fundamental","pubTime":"2025-10-07 01:39","pubTimestamp":1759772387,"startTime":"0","endTime":"0","summary":"BUZZ-Amgen stock falls as Repatha gets direct sales price cut** Amgen AMGN.O on Mon launched direct-to-consumer U.S. sales of cholesterol drug Repatha at discount $239/mo cash price; stock down 1.4%  ** Move responds to U.S. political pressure to lower drug prices; new price nearly 60% below list, but only for uninsured cash buyers  ** AMGN says 98% of insured U.S. patients already get Repatha with co-pays as low as $15  ** Repatha sales hit $2.2 bln last yr** AMGN stock up ~13% YTD, lagging Nasdaq .IXIC rise of 19%    ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nL6N3VN0QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0058720904.USD","BK4588","BK4566","LU2242646821.SGD","BK4533","BK4139","IE00B2B36J28.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU2242652126.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1023059063.AUD","LU0868494617.USD","BK4599","LU1061106388.HKD","LU1571399168.USD","LU0289739699.SGD","LU2468319806.SGD","BK4581","SG9999001440.SGD","LU2089984988.USD","LU0122379950.USD","AMGN","LU2112291526.USD","LU1983299246.USD","IE0009355771.USD","BK4534","BK4585"],"gpt_icon":0},{"id":"2573601969","title":"BUZZ-COVID vaccine makers fall after US CDC pulls support for the shot","url":"https://stock-news.laohu8.com/highlight/detail?id=2573601969","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573601969?lang=en_us&edition=fundamental","pubTime":"2025-10-07 00:35","pubTimestamp":1759768547,"startTime":"0","endTime":"0","summary":"BUZZ-COVID vaccine makers fall after US CDC pulls support for the shot** Shares of COVID vaccine makers fall after U.S. CDC pulls broad support for COVID-19 shots, saying they should be administered through shared decision-making with a healthcare provider and the individual** Shares of Pfizer PFE.N down 1.3%, Moderna MRNA.O down 1.7% and Novavax down 1.7% ** The Centers for Disease Control and Prevention's move is in accordance with recommendations from Health Secretary Robert F. Kennedy Jr.'s hand-picked vaccine advisory panel** Including session's move, PFE up 1.7%, MRNA down 32.5%, NVAX up 15.6% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nL3N3VN0YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0985481810.HKD","NVAX","BK4588","BK4532","BK4592","LU0456855351.SGD","LU0868494617.USD","IE00BBT3K403.USD","SG9999001176.USD","BK4568","SG9999013999.USD","LU0321505868.SGD","SG9999001176.SGD","IE00B19Z3581.USD","BK4533","BK4501","IE00BLSP4452.SGD","SG9999002224.SGD","LU0225284248.USD","LU0321505439.SGD","SG9999003800.SGD","LU1023059063.AUD","LU0306807586.USD","BK4548","MRNA","LU1066051498.USD","BK4534","PFE","LU0225771236.USD","SGXZ57979304.SGD","SG9999002232.USD","BK4551","LU1894683264.USD","BK4550","BK4007","LU0122379950.USD","IE0002270589.USD","LU1057294990.SGD","BK4139","LU0234572021.USD","LU1066053197.SGD","IE000M9KFDE8.USD","BK4599","IE00B19Z3B42.SGD","LU1883839398.USD","BK4581","LU0170899867.USD","SG9999011175.SGD","LU0058720904.USD"],"gpt_icon":1},{"id":"2573378609","title":"Martin Capital Liquidates its Diageo Position: What That Means for the Alcoholic Beverages Titan","url":"https://stock-news.laohu8.com/highlight/detail?id=2573378609","media":"Motley Fool","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573378609?lang=en_us&edition=fundamental","pubTime":"2025-10-06 23:47","pubTimestamp":1759765620,"startTime":"0","endTime":"0","summary":"Martin Capital sold 32,525 shares of Diageo, an estimated $3.28 million trade based on average pricing for the quarter ended September 30, 2025.The transaction represents 1.3% of Martin Capital Partners’ 13F reportable assets under management as of the third quarter of 2025.Martin Capital's post-trade stake: zero shares; position value reduced to $0.The position previously accounted for 1.29% of the fund’s assets as of September 30, 2025, marking a complete exit from a notable holding.","market":"nz","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F2aaa0626f8846fe4dc9ac3102ff548ca70099aff-1536x1024.png&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F2aaa0626f8846fe4dc9ac3102ff548ca70099aff-1536x1024.png&op=resize&w=165&h=104"],"rights":{"source":"fool_stock","url":"https://www.fool.com/coverage/filings/2025/10/06/martin-capital-liquidates-its-diageo-position-what-that-means-for-the-alcoholic-beverages-titan/","rn_cache_url":null,"customStyle":"","selectors":".main-contain, #article-page","filters":"#sticky-wrapper, .navigation, .article-page-end, .foot, .author-tagline, .author-inline, .footer, .soc-share, .wysiwyg, .related-content","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/coverage/filings/2025/10/06/martin-capital-liquidates-its-diageo-position-what-that-means-for-the-alcoholic-beverages-titan/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0868494617.USD","TWI","IE00B4R5TH58.HKD","LU0289739699.SGD","BK4523","BK4585","IE00BJJMRZ35.SGD","BK4099","IE00BJT1NW94.SGD","LU2089984988.USD","LU0109394709.USD","LU0320765992.SGD","LU1061106388.HKD","BK4152","BK4588","LU2242646821.SGD","LU0889565916.HKD","IE0002141913.USD","BK4599","BK4566","LU0122379950.USD","LU1057294990.SGD","LU2468319806.SGD","LU1571399168.USD","IE00B2B36J28.USD","LU2242652126.USD","AMGN","SG9999001440.SGD","BK4534","IE00BFTCPJ56.SGD","IE0009355771.USD","TTM","LU2112291526.USD","LU0058720904.USD","BK4581","BK4533","LU1023059063.AUD","LU1983299246.USD","BK4139"],"gpt_icon":0},{"id":"2573280606","title":"Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2573280606","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573280606?lang=en_us&edition=fundamental","pubTime":"2025-10-06 23:33","pubTimestamp":1759764780,"startTime":"0","endTime":"0","summary":"Something unusual is happening with biotech stocks: They are going up.The SPDR S&P Biotech exchange-traded fund, which tracks a broad selection of biotech names, has shot up 8.9% since September 25, just more than a week ago.Often referred to by its ticker symbol, XBI, the ETF is now up 15.9% on the year, outperforming the S&P 500 index, which is up 14.4% over the same period. That's a remarkable run for a sector that hasn't had much going on since early 2021.The biotech run-up over the past week or so has been fueled by the same drug-pricing deal between Pfizer and President Donald Trump that set off a surge in Big Pharma share prices last Tuesday, along with a spate of acquisitions.\"Biotech specialists became increasingly optimistic through September as the rally off of the early April lows continued,\" TD Cowen's biotechnology team wrote in a note published last Wednesday. \"After several quarters o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SDS","SPXU",".SPX","LU2125154778.USD","MESmain","VOO","XBI","LU1116320901.HKD","LU0208291251.USD","LU1989772840.SGD","LU0061475181.USD","LU0237698245.USD","BK4550","SH","LU2361045086.USD","OEX","BMY","LU0868494617.USD","UPRO","BK4588","LU1116320737.USD","LU1066051498.USD","BK4592","OEF","LU0965509101.SGD","LU0106261372.USD","IE000M9KFDE8.USD","ESmain","BK4516","LU0170899867.USD","MRK","BK4599","LU0320765646.SGD","SG9999002224.SGD","IE00BN8TJ469.HKD","SPY","IE0002141913.USD","LU1323610961.USD","LU1941712348.USD","LU1868836914.USD","SSO","SG9999015341.SGD","LU0122379950.USD","LU1093756325.SGD","IVV","LU2361044865.SGD","LU1291159041.SGD","SG9999011175.SGD","LU1917777945.USD"],"gpt_icon":1},{"id":"1105936043","title":"Eli Lilly Announces $1 Billion Investment in India to Expand Manufacturing Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1105936043","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105936043?lang=en_us&edition=fundamental","pubTime":"2025-10-06 23:10","pubTimestamp":1759763443,"startTime":"0","endTime":"0","summary":"During early Monday trading in the US stock market, Eli Lilly (LLY) shares gained 1.7% following the company's announcement of a $1 billion investment in India to expand its manufacturing footprint,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361044865.SGD","LU2357305700.SGD","MNDmain","IE0002141913.USD","LU1868836757.USD","LU0320765059.SGD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU1035775433.USD","BK4599","LU2237443622.USD","SG9999001176.SGD","LU2087625088.SGD","LU2237443549.SGD","LU1093756325.SGD","LU2324357040.USD","LU0432979614.USD","LU1069344957.HKD","LU0106261372.USD","LU1623119135.USD","IE00B4R5TH58.HKD","LU0061475181.USD","LU2265009873.SGD","LU1267930730.SGD","SG9999015952.SGD","LU1720051108.HKD","LU0823416689.USD","LU2237443382.USD","LU1804176565.USD","LU0234572021.USD","LU2108987350.USD","LU1814569148.SGD","IE00B2B36J28.USD","LU1983299246.USD","SG9999013999.USD","LU2491050071.SGD","LU0471298694.HKD","BK4007","LU2471134523.USD","LU2746668974.SGD","BK4533","LU1917777945.USD","LU0094547139.USD","LU2361044949.HKD","SGXZ51526630.SGD","LU0096364046.USD","IE00BJT1NW94.SGD","LU0203202063.USD","LU0323591593.USD","LU2236285917.USD","LU2468319806.SGD","LU2746668461.USD","SGXZ57979304.SGD","LU0079474960.USD","LU0943347566.SGD","LU0882574055.USD","SG9999015986.USD","BK4585","LU0640476718.USD","LU2471134879.HKD","LU0823434740.USD","SG9999001176.USD","LU1061106388.HKD","LU0353189763.USD","LU0203201768.USD","LU2471134952.CNY","LU2112291526.USD","LU2361045086.USD","LU2552382215.SGD","LU0006306889.USD","LU0109391861.USD","LU0354030438.USD","SG9999017495.SGD","IE0004445239.USD","LU0320765992.SGD","LU0889565916.HKD","LU0786609619.USD","LU0289739699.SGD","LU1712237335.SGD","LU1988902786.USD","LU2360106947.USD","SGXZ99366536.SGD","BK4516","LU0882574139.USD","SG9999018857.SGD","LU0122379950.USD","LU0820561818.USD","IE0009355771.USD","LU0823434583.USD","BK4534","LU2750360997.AUD","GB00BDT5M118.USD","SG9999014914.USD","SGXZ31699556.SGD","SG9999014898.SGD","LU0058720904.USD","LU0385154629.USD","LU0456855351.SGD","SG9999015945.SGD","LU2462157665.USD","LU1868836914.USD","BK4581","LU2237443978.SGD","IE00BK4W5M84.HKD","SG9999014880.SGD","LU1551013425.SGD","LLY","LU2237443465.HKD","LU2456880835.USD","LU2237438978.USD","LU1868837300.USD","LU0471298777.SGD","LU1548497426.USD","LU1093756168.USD","LU0256863902.USD","LU0353189680.USD","LU2089984988.USD","LU0672654240.SGD","IE00BJLML261.HKD","LU0708995401.HKD","LU0354030511.USD","LU2552382058.USD","LU1291159041.SGD","LU2023250504.SGD","BK4588","LU2602419157.SGD","LU1989771016.USD","LU0114720955.EUR","LU0689472784.USD","LU0097036916.USD","LU1127390331.HKD","LU1868836591.USD","LU2106854487.HKD","SG9999015978.USD","LU0316494557.USD","LU0417517546.SGD","SGXZ81514606.USD","LU0256863811.USD","IE00B1BXHZ80.USD","LU1366192091.USD","LU0198837287.USD","SG9999018865.SGD","LU2063271972.USD","LU0266013472.USD","LU2264538146.SGD","IE00BK4W5L77.USD","LU2211815571.USD","LU2750360641.GBP","LU2461242641.AUD","LU0238689110.USD","LU1280957306.USD","LU1720051017.SGD","LU0466842654.USD","SG9999014906.USD","LU1551013342.USD","LU2417539215.USD","LU1057294990.SGD","LU1232071149.USD","LU2237443895.HKD","LU2471134796.USD","LU1868837136.USD","LU0109394709.USD","LU2491049909.HKD","LU1064131342.USD","LU0820561909.HKD","LU1023059063.AUD","LU2552382132.HKD","LU2491050154.USD","LU1974910355.USD"],"gpt_icon":0},{"id":"2573608427","title":"GoodRx Expands Affordable Access to Cholesterol Drug Repatha","url":"https://stock-news.laohu8.com/highlight/detail?id=2573608427","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573608427?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:56","pubTimestamp":1759758993,"startTime":"0","endTime":"0","summary":"GoodRx  said Monday it is expanding the availability of Amgen's  cholesterol drug Repatha at a lower price.Starting Monday, patients will be able to use GoodRx to buy Repatha for $239 at over 70,000 pharmacies in the US, GoodRx said, adding that the price represents a savings of about 60% off the retail pharmacy list price.GoodRx shares were up 3.5% in early trading, while Amgen was down 0.5%.Price: 4.69, Change: +0.16, Percent Change: +3.53","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","IE00B2B36J28.USD","LU0868494617.USD","LU1061106388.HKD","BK4167","GDRX","LU2242652126.USD","IE0002141913.USD","BK4533","AMGN","LU1023059063.AUD","BK4534","LU2468319806.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU1571399168.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0889565916.HKD","LU1983299246.USD","LU0122379950.USD","LU1057294990.SGD","LU0109394709.USD","BK4139","LU0320765992.SGD","BK4566","LU2089984988.USD","IE00BJT1NW94.SGD","BK4599","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU2242646821.SGD","BK4581","LU0058720904.USD","LU2112291526.USD"],"gpt_icon":0},{"id":"2573608923","title":"Amgen Introduces Direct-to-Patient Access for Repatha in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2573608923","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573608923?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:46","pubTimestamp":1759758415,"startTime":"0","endTime":"0","summary":"Amgen  said Monday it launched AmgenNow, a direct-to-patient program in the US starting with its cholesterol drug Repatha, or evolucumab.The company said eligible patients can buy Repatha through the program for $239 per month, about 60% lower than the drug's current list price. The program is open to patients who are uninsured, in high-deductible health plans, or prefer to pay out of pocket, according to Amgen.The program will be available to all Repatha patients, including those on Medicare and Medicaid, and will not require step therapy or prior authorization, the company said.Price: 297.00, Change: -0.89, Percent Change: -0.30","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0289739699.SGD","BK4588","LU0058720904.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","IE00BJT1NW94.SGD","BK4581","LU2468319806.SGD","LU1983299246.USD","LU0320765992.SGD","BK4139","LU2112291526.USD","LU1057294990.SGD","LU1571399168.USD","LU2089984988.USD","SG9999001440.SGD","LU0889565916.HKD","BK4599","LU0868494617.USD","LU1023059063.AUD","IE0009355771.USD","LU0122379950.USD","AMGN","BK4533","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU2242652126.USD","BK4566","IE00BJJMRZ35.SGD","BK4585","BK4534","LU2242646821.SGD","IE0002141913.USD"],"gpt_icon":0},{"id":"2573398670","title":"BRIEF-Amgen Makes Repatha® Available Through Amgennow, A Direct-To-Patient Program In The U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2573398670","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573398670?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:10","pubTimestamp":1759756247,"startTime":"0","endTime":"0","summary":"BRIEF-Amgen Makes Repatha Available Through Amgennow, A Direct-To-Patient Program In The U.S.Oct 6 (Reuters) - Amgen Inc AMGN.O:AMGEN MAKES REPATHA AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROG","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA4WVTZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","LU1061106388.HKD","LU2112291526.USD","IE0009355771.USD","LU0289739699.SGD","LU2242652126.USD","SG9999001440.SGD","BK4581","LU0889565916.HKD","LU1023059063.AUD","BK4566","LU0109394709.USD","LU0868494617.USD","LU1057294990.SGD","IE0002141913.USD","LU2468319806.SGD","BK4599","AMGN","IE00B2B36J28.USD","LU0320765992.SGD","BK4534","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4533","BK4139","LU2089984988.USD","IE00BJJMRZ35.SGD","BK4585","BK4588","LU0122379950.USD","LU1571399168.USD","LU1983299246.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"2573772196","title":"Amgen Makes Repatha® Available Through Amgennow, a Direct-to-Patient Program in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2573772196","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573772196?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:00","pubTimestamp":1759755649,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA4WVTZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJT1NW94.SGD","LU1023059063.AUD","LU1571399168.USD","IE0002141913.USD","LU0058720904.USD","LU1983299246.USD","BK4585","BK4139","LU0122379950.USD","LU2089984988.USD","BK4581","BK4533","BK4588","IE00BFTCPJ56.SGD","LU1057294990.SGD","BK4534","LU0868494617.USD","LU2242646821.SGD","LU0109394709.USD","LU0889565916.HKD","LU2112291526.USD","LU0289739699.SGD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU1061106388.HKD","BK4566","LU2468319806.SGD","LU2242652126.USD","AMGN","IE0009355771.USD","BK4599","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2573677217","title":"Amgen: Program Open to All Patients, Including Those Who Are Uninsured or in High-Deductible Health Plans or Prefer to Pay With Cash or Out of Pocket","url":"https://stock-news.laohu8.com/highlight/detail?id=2573677217","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573677217?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:00","pubTimestamp":1759755600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nP8N3LN0MQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001440.SGD","LU2242652126.USD","AMGN","LU1571399168.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","IE0002141913.USD","LU0058720904.USD","IE0009355771.USD","LU2089984988.USD","LU2468319806.SGD","BK4533","BK4581","LU1983299246.USD","BK4599","LU0122379950.USD","LU1061106388.HKD","BK4534","BK4585","IE00BFTCPJ56.SGD","BK4139","IE00BJT1NW94.SGD","BK4566","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU2112291526.USD","LU0109394709.USD","IE00B2B36J28.USD","LU0289739699.SGD","LU0889565916.HKD","LU0320765992.SGD","BK4588"],"gpt_icon":0},{"id":"2573667720","title":"Amgen: Repatha to Be Available Through Amgennow at a Monthly Price of $239, Nearly 60% Lower Than Current U.S. List Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2573667720","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573667720?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:00","pubTimestamp":1759755600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nP8N3LN0MQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0868494617.USD","IE00BFTCPJ56.SGD","LU2242646821.SGD","BK4588","IE00B4R5TH58.HKD","LU1057294990.SGD","BK4585","LU0320765992.SGD","LU0109394709.USD","BK4534","AMGN","BK4599","LU0058720904.USD","LU2468319806.SGD","LU1571399168.USD","BK4139","BK4581","LU1983299246.USD","LU2112291526.USD","LU2242652126.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","IE0002141913.USD","LU0122379950.USD","LU1023059063.AUD","SG9999001440.SGD","LU0889565916.HKD","LU2089984988.USD","BK4533","IE0009355771.USD","LU0289739699.SGD","BK4566","IE00B2B36J28.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2573488677","title":"Amgen to sell cholesterol drug at 60% discount direct to US consumers","url":"https://stock-news.laohu8.com/highlight/detail?id=2573488677","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573488677?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:00","pubTimestamp":1759755600,"startTime":"0","endTime":"0","summary":"Amgen to sell cholesterol drug at 60% discount direct to US consumersDrug will cost $239 a month via portalMove follows July warning from TrumpPharma companies under pressure to match lower prices in other countriesBy Deena Beasley","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nL2N3VM05V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772923.USD","BK4588","LU1037948897.HKD","BK4599","LU1934455863.HKD","BK4568","LU2242652126.USD","LU2242646821.SGD","LU0868494617.USD","LU2361044865.SGD","LU0238689110.USD","LU1974910355.USD","SG9999011175.SGD","LU1035773651.USD","LU0170899867.USD","IE000M9KFDE8.USD","LU0321505439.SGD","IE0002270589.USD","IE00BBT3K403.USD","LU1699723380.USD","LU1894683264.USD","MRK","LU0965509101.SGD","LU1917777945.USD","LU1023059063.AUD","IE00BLSP4239.USD","BK4534","LU0321505868.SGD","LU1116320737.USD","LU0965509283.SGD","LU1934455277.USD","LU1066051498.USD","LU0266013472.USD","LU0225771236.USD","LU0985320562.USD","LU2106854487.HKD","LU0203345920.USD","IE00B19Z3581.USD","LU0109394709.USD","LU1430594728.SGD","LU2361044949.HKD","SG9999002232.USD","SG9999014567.USD","SGXZ57979304.SGD","LU1061106388.HKD","BK4533","AMGN","LU1571399168.USD","BK4581"],"gpt_icon":1},{"id":"2573214677","title":"Amgen: Plans to Make Amgennow Accessible via the Trumprx Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2573214677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573214677?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:00","pubTimestamp":1759755600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nP8N3LN0MQ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001440.SGD","LU2242652126.USD","AMGN","LU1571399168.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","IE0002141913.USD","LU0058720904.USD","IE0009355771.USD","LU2089984988.USD","LU2468319806.SGD","BK4533","BK4581","LU1983299246.USD","BK4599","LU0122379950.USD","LU1061106388.HKD","BK4534","BK4585","IE00BFTCPJ56.SGD","BK4139","IE00BJT1NW94.SGD","BK4566","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU2112291526.USD","LU0109394709.USD","IE00B2B36J28.USD","LU0289739699.SGD","LU0889565916.HKD","LU0320765992.SGD","BK4588"],"gpt_icon":0},{"id":"2573667412","title":"Press Release: Phathom Pharmaceuticals Appoints Sanjeev Narula as Chief Financial and Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2573667412","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573667412?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:00","pubTimestamp":1759752000,"startTime":"0","endTime":"0","summary":"-- Sanjeev Narula brings proven success in scaling commercial-stage. biopharma companies with expertise in capital and investor strategies,-- Appointment strengthens Phathom's leadership team and ability to execute. FLORHAM PARK, N.J., Oct. 06, 2025  -- Phathom Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal  diseases, today announced the appointment of Sanjeev Narula as Chief Financial and Business Officer.Mr. Narula commented, \"This is an exciting moment to join Phathom, with VOQUEZNA gaining traction and a clear path for continued growth. I look forward to working with the talented team to drive financial performance and help unlock the company's full potential.\". Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases. Phathom has in-licensed the exclusive rights to vonoprazan, a first-in-class potassiu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0170899867.USD","IE00B19Z3581.USD","LU1057294990.SGD","BK4599","LU0456855351.SGD","LU0225284248.USD","IE00BLSP4239.USD","LU0225771236.USD","LU1066051498.USD","LU0289739699.SGD","BK4592","LU1894683264.USD","BK4581","BK4534","SG9999011175.SGD","BK4007","SGXZ57979304.SGD","BK4568","SG9999001176.USD","LU1023059063.AUD","LU0122379950.USD","IE00BLSP4452.SGD","IE00B19Z3B42.SGD","LU1066053197.SGD","R","BK4585","LU1894683348.USD","BK4022","BK4232","SG9999001176.SGD","SG9999002232.USD","BK4588","LU0321505868.SGD","LU1883839398.USD","BK4533","LU0985481810.HKD","LU0321505439.SGD","SG9999003800.SGD","IE00BBT3K403.USD","LU0306806265.USD","PHAT","SG9999013999.USD","LU0234572021.USD","IE0002270589.USD","LU0306807586.USD","SG9999002224.SGD","LU0058720904.USD","IE000M9KFDE8.USD"],"gpt_icon":1},{"id":"1184174937","title":"Eli Lilly Plans to Invest Over $1 Billion in India to Boost Production Capacity for Weight Loss Drugs and Other Key Medications","url":"https://stock-news.laohu8.com/highlight/detail?id=1184174937","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184174937?lang=en_us&edition=fundamental","pubTime":"2025-10-06 18:44","pubTimestamp":1759747473,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY.US) announced on Monday its plans to invest over $1 billion in India over the coming years, working with local pharmaceutical manufacturers to advance production and supply network...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","LU2360106947.USD","LU0672654240.SGD","SG9999001176.USD","LU0417517546.SGD","LU2108987350.USD","LU2265009873.SGD","LU2468319806.SGD","SG9999014914.USD","LU1061106388.HKD","LU0820561909.HKD","LU0289739699.SGD","LU0109391861.USD","LU0266013472.USD","IE00B2B36J28.USD","LU0198837287.USD","LU1814569148.SGD","LU1551013425.SGD","LU0006306889.USD","SGXZ81514606.USD","LU2552382215.SGD","LU2237443465.HKD","LU0096364046.USD","LU1267930730.SGD","LU2471134796.USD","LU0320765992.SGD","LU2237443382.USD","IE00BFTCPJ56.SGD","LU0820561818.USD","LU1035775433.USD","LU0385154629.USD","LU0320765059.SGD","LU2023250504.SGD","LU2746668461.USD","LU0203202063.USD","LU1712237335.SGD","LU0823416689.USD","BK4588","BK4534","IE0002141913.USD","LU0689472784.USD","LU0823434740.USD","LU1804176565.USD","LU2471134879.HKD","BK4533","LU0708995401.HKD","SGXZ51526630.SGD","LU1069344957.HKD","LU0943347566.SGD","LU2264538146.SGD","LU0323591593.USD","LU0061475181.USD","LU0471298777.SGD","LU0640476718.USD","LU2361044949.HKD","LU0316494557.USD","LU0882574055.USD","LU2237443895.HKD","SG9999018857.SGD","LU0203201768.USD","LU0823434583.USD","LU1280957306.USD","LU1023059063.AUD","SG9999018865.SGD","LU2237438978.USD","LU2357305700.SGD","LU0256863902.USD","LU2236285917.USD","IE0004445239.USD","SG9999014880.SGD","LU2089984988.USD","IE0009355771.USD","LU0106261372.USD","LU0079474960.USD","LU0456855351.SGD","LU2491050154.USD","LU1093756325.SGD","LU2456880835.USD","SG9999015986.USD","SG9999015945.SGD","LU2750360997.AUD","LU2237443549.SGD","LU2461242641.AUD","MNDmain","IE00BK4W5L77.USD","LU2237443978.SGD","SG9999001176.SGD","LU2462157665.USD","LU1988902786.USD","LU2471134952.CNY","LU2746668974.SGD","LU1366192091.USD","SG9999014898.SGD","LU0109394709.USD","LU1983299246.USD","GB00BDT5M118.USD","SG9999015952.SGD","LU0122379950.USD","SGXZ31699556.SGD","IE00BJLML261.HKD","LU1623119135.USD","SG9999013999.USD","LU2063271972.USD","LU1093756168.USD","SG9999017495.SGD","LU1868836591.USD","LU1551013342.USD","LU1232071149.USD","LU2106854487.HKD","LU0353189763.USD","BK4585","LU1057294990.SGD","LU1868836757.USD","LU0786609619.USD","LU1291159041.SGD","LU2471134523.USD","LU1720051017.SGD","LU0882574139.USD","LU0058720904.USD","SG9999015978.USD","LU1989771016.USD","LU2491050071.SGD","BK4007","IE00B1BXHZ80.USD","LU0354030438.USD","LU1868837136.USD","LU2211815571.USD","LU2602419157.SGD","LU0097036916.USD","IE00BK4W5M84.HKD","BK4581","LU0354030511.USD","LU1974910355.USD","SGXZ57979304.SGD","LU2491049909.HKD","LU0466842654.USD","LU0094547139.USD","LU1917777945.USD","LU0353189680.USD","LU1720051108.HKD","LU2417539215.USD","BK4516","LU0471298694.HKD","LU2552382058.USD","LU1868837300.USD","LU1868836914.USD","BK4599","LU0256863811.USD","LU1127390331.HKD","LU2087625088.SGD","LU2324357040.USD","LU0432979614.USD","LU2361045086.USD","LU1064131342.USD","SGXZ99366536.SGD","LU2237443622.USD","IE00BJJMRZ35.SGD","LU1548497426.USD","LLY","LU2552382132.HKD","IE00BJT1NW94.SGD","LU2112291526.USD","SG9999014906.USD","IE00B4R5TH58.HKD","LU2750360641.GBP","LU2361044865.SGD","LU0889565916.HKD","LU0238689110.USD","LU0114720955.EUR"],"gpt_icon":1},{"id":"2573867837","title":"3 Reasons to Buy Pfizer Stock Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2573867837","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573867837?lang=en_us&edition=fundamental","pubTime":"2025-10-06 16:59","pubTimestamp":1759741140,"startTime":"0","endTime":"0","summary":"After years of underperformance, the future is looking brighter for the drugmaker.","market":"nz","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F835811%2Fresearch-scientists-drugs-pharma-biotech.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F835811%2Fresearch-scientists-drugs-pharma-biotech.jpg&op=resize&w=165&h=104"],"rights":{"source":"fool_stock","url":"https://www.fool.com/investing/2025/10/06/3-reasons-to-buy-pfizer-stock-now/","rn_cache_url":null,"customStyle":"","selectors":".main-contain, #article-page","filters":"#sticky-wrapper, .navigation, .article-page-end, .foot, .author-tagline, .author-inline, .footer, .soc-share, .wysiwyg, .related-content","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/10/06/3-reasons-to-buy-pfizer-stock-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0985481810.HKD","IE0002270589.USD","LU0306806265.USD","BK4592","IE00B19Z3581.USD","LU0289739699.SGD","BK4007","LU0234572021.USD","BK4581","LU0321505868.SGD","LU0456855351.SGD","IE000M9KFDE8.USD","LU1883839398.USD","LU0321505439.SGD","SGXZ57979304.SGD","IE00BLSP4239.USD","LU0306807586.USD","LU1023059063.AUD","LU1057294990.SGD","LU0868494617.USD","LU1894683264.USD","SG9999001176.USD","BK4550","BK4568","IE00B19Z3B42.SGD","LU0170899867.USD","BK4599","SG9999011175.SGD","SG9999002224.SGD","LU1894683348.USD","IE00BBT3K403.USD","PFE","BK4534","SG9999002232.USD","SG9999001176.SGD","LU1066051498.USD","SG9999013999.USD","LU0225284248.USD","LU1066053197.SGD","MTSR","BK4533","IE00BLSP4452.SGD","SG9999003800.SGD","BK4139","BK4585","BK4588","LU0122379950.USD","LU0225771236.USD","LU0058720904.USD"],"gpt_icon":1},{"id":"2573622397","title":"Eli Lilly to Invest Over $1 Bln in India to Collaborate With Contract Drugmakers","url":"https://stock-news.laohu8.com/highlight/detail?id=2573622397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573622397?lang=en_us&edition=fundamental","pubTime":"2025-10-06 15:09","pubTimestamp":1759734583,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nL3N3VM02U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1069344957.HKD","LU2211815571.USD","LU2491049909.HKD","SG9999018857.SGD","IE00B4R5TH58.HKD","LU1974910355.USD","LU1917777945.USD","LU2106854487.HKD","LU0289739699.SGD","LU2236285917.USD","LU2491050154.USD","LU1093756168.USD","SG9999017495.SGD","BK4599","LU0882574055.USD","IE00BK4W5L77.USD","IE0004445239.USD","LU0353189680.USD","IE00BJT1NW94.SGD","LU1868836591.USD","IE00BK4W5M84.HKD","LU0823434583.USD","LU2112291526.USD","LU2462157665.USD","BK4534","LU2417539215.USD","LU2461242641.AUD","LU0823434740.USD","LU0114720955.EUR","SG9999015986.USD","SGXZ51526630.SGD","LU1720051108.HKD","LU0889565916.HKD","LU0266013472.USD","LU0354030438.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","SG9999001176.SGD","LU1267930730.SGD","LU1868837300.USD","LLY","LU1291159041.SGD","SG9999014880.SGD","LU1366192091.USD","LU2552382058.USD","LU2552382215.SGD","LU0689472784.USD","LU1232071149.USD","LU0353189763.USD","LU2237443549.SGD"],"gpt_icon":0},{"id":"2573648904","title":"2 Beaten-Down Stocks Primed for a Comeback","url":"https://stock-news.laohu8.com/highlight/detail?id=2573648904","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573648904?lang=en_us&edition=fundamental","pubTime":"2025-10-06 02:30","pubTimestamp":1759689000,"startTime":"0","endTime":"0","summary":"The market is sleeping on these stocks, but you don't have to.","market":"nz","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F835449%2Fpharmacist-talking-to-patient.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F835449%2Fpharmacist-talking-to-patient.jpg&op=resize&w=165&h=104"],"rights":{"source":"fool_stock","url":"https://www.fool.com/investing/2025/10/05/2-beaten-down-stocks-primed-for-a-comeback/","rn_cache_url":null,"customStyle":"","selectors":".main-contain, #article-page","filters":"#sticky-wrapper, .navigation, .article-page-end, .foot, .author-tagline, .author-inline, .footer, .soc-share, .wysiwyg, .related-content","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/10/05/2-beaten-down-stocks-primed-for-a-comeback/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0566484027.USD","LU2237438978.USD","BK4093","IE00B19Z9P08.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","IE00B2B36J28.USD","LU1778281490.HKD","LU0154236417.USD","IE00BJT1NW94.SGD","BK4007","NVO","LU0109394709.USD","LU2236285917.USD","IE0002270589.USD","BK4533","VRTX","LU0079474960.USD","IE0009355771.USD","LU0289739699.SGD","LU2362541513.USD","SG9999013999.USD","BK4588","IE00B19Z3581.USD","LU2362540622.SGD","LU0256863811.USD","BK4599","IE0002141913.USD","LU0061475181.USD","LU0889565916.HKD","LU0058720904.USD","LU1559883803.SGD","LU2417539215.USD","LU0234570918.USD","VERX","BK4023","BK4567","LU2324357040.USD","LU0417517546.SGD","LU2462157665.USD","IE00B19Z3B42.SGD","BK4585","IE00BZ1G4Q59.USD","LU1093756168.USD","CF","LU1585245621.USD","SGXZ57979304.SGD","LU0320765992.SGD","LU0823416689.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":13,"pageCount":1,"totalSize":255,"code":"91000000","status":"200"}]}}